STE.NYSESteris PLC

Form 4: STERIS Director Nirav Shah Receives Equity Awards

Sentiment:

Insider Transaction Report

📋All filings for Steris PLC
🔒Login to Follow

STERIS plc Director Nirav Shah was granted 1,407 nonqualified stock options and 487 career restricted stock units, both immediately vested.

Summary

  • Director Nirav R. Shah of STERIS plc (STE) was granted equity awards.
  • Awards include 1,407 nonqualified stock options with an exercise price of $242.85.
  • These stock options are fully vested and immediately exercisable as of August 8, 2025, and expire on August 8, 2035.
  • Additionally, 487 Career Restricted Stock Units (RSUs) were granted.
  • Each RSU represents the right to receive one STERIS ordinary share.
  • These RSUs are fully vested immediately as of August 8, 2025, and will be settled six months after the cessation of Director Shah's Board service.
  • Following these transactions, Director Shah beneficially owns 1,407 stock options and a total of 6,503 Career Restricted Stock Units.

Sentiment

Score: 7

Explanation: The filing indicates a routine equity grant to a director, which is generally positive for aligning interests but does not suggest significant new information about company performance or strategy.

Positives

  • Grant of equity awards aligns Director Shah's interests with shareholders.
  • Immediate vesting of both stock options and RSUs provides immediate beneficial ownership.
  • The RSU structure encourages long-term commitment, with settlement tied to cessation of Board service.

Negatives

  • No immediate cash proceeds from the RSU grant, as settlement occurs post-service.
  • The stock option exercise price of $242.85 means the options are only valuable if STERIS's stock price rises above this level.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: Director's interests are further aligned with shareholder value through equity ownership.
  • Employees: No direct impact mentioned.
  • Customers: No direct impact mentioned.
  • Suppliers: No direct impact mentioned.
  • Creditors: No direct impact mentioned.

Key Dates

DateDescription
08/08/2025Date of earliest transaction, grant date for stock options and Career Restricted Stock Units, and date options become exercisable and RSUs become vested.
08/12/2025Signature date of the reporting person's authorized representative.
08/08/2035Expiration date of the nonqualified stock options.

Recommendation

hold

This Form 4 filing details a routine equity compensation grant to a director and does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. It primarily serves to disclose changes in beneficial ownership as required by regulations.

Keywords

STERIS plc, STE, Nirav Shah, SEC Form 4, Stock Options, Restricted Stock Units, Equity Grant, Director Compensation, Insider Transaction

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.